Quality inspectors on Sinovac vaccine production lines use digital technology platforms to monitor the quality and efficiency of vaccine packaging on December 20. Photos: Li Hao/Global Times
Quality inspectors on Sinovac vaccine production lines use digital technology platforms to monitor the quality and efficiency of vaccine packaging on December 20. Photos: Li Hao/Global Times

dpa/GNA – Brazil’s national authority for medical supervision Anvisa on Sunday granted emergency approval to the Covid-19 vaccines manufactured by Chinese firm Sinovac and British partners AstraZeneca and Oxford University.

There are around 6 million doses of the Sinovac jab available, as the state of Rio de Janeiro made a deal with the Chinese manufacturer.

Efforts to import 2 million doses of the AztraZeneca/Oxford University vaccine from India initially failed on Friday.

President Jair Bolsonaro and Rio de Janeiro’s governor, Joao Doria, are in competition to become the first person to be photographed while receiving the jab.

Brazil is one of the countries hit hardest by the pandemic. Some 8.5 million people have caught the virus in the country of 210 million inhabitants, and more than 209,000 patients have died of Covid-19.

Due to the drastic increase in acute cases, the health system in Manaus in the Amazon region recently collapsed, with oxygen having to be airlifted into the metropolis.

Disclaimer: News Ghana is not responsible for the reportage or opinions of contributors published on the website.

Send your news stories to [email protected] and via WhatsApp on +1-508-812-0505 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.